Bayer today announced that one late-breaking presentation along with five posters across its cardiovascular programs will be featured at the Heart Failure Society of Amer ...
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of upcoming presentations at the 10th Joint ACTRIMS-ECTRIMS Meeting, also referred to as MSToronto2026, being held October 21-23, ...
Eli Lilly and Company (NYSE: LLY) will present new data across its dermatology portfolio at the 2026 Fall Clinical Dermatology ...
Background Heart failure (HF) remains associated with high mortality worldwide despite advances in guideline-directed therapy ...
Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and ...
RINVOQ is the first and only systemic medication approved in the European Union to treat adult and adolescent patients with non-segmental vitiligo (NSV) who are candidates for systemic therapy Phase 3 ...
Cardiovascular disease remains the leading cause of death across European Society of Cardiology (ESC) member countries. Yet ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The global AI race is creating a stark divide in data center reception. While countries like ...
The Texas Department of State Health Services (DSHS) announced last week that it would not release its biannual maternal mortality report until December, pushing the release date to after the November ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results